Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
NCT01310881
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Depression
Interventions
DRUG:
NSI-189 Phosphate
Sponsor
Neuralstem Inc.